Download App

Log in to access Online Inquiry
Company Overview More
Peilinong Benfang Co., Ltd. (formerly known as Peili Holdings Co., Ltd.) is an investment holding company mainly engaged in concentrated traditional Chinese medicine formula granule products. The company operates through five business divisions. China concentrated traditional Chinese Medicine Formula granule Division is engaged in the production and sales of concentrated traditional Chinese medicine formula granule products in China. Hong Kong concentrated Chinese Medicine Formula granule Division is mainly engaged in the sales of concentrated traditional Chinese medicine formula granule products in Hong Kong, China, excluding sales through self-run clinics. The branch of traditional Chinese medicine health products is mainly engaged in the production and sales of health products in Hong Kong, China and other countries and regions. The clinic division mainly provides Chinese medicine outpatient services and sells concentrated Chinese medicine formula granule products through self-run clinics. The planting Division is mainly engaged in the cultivation and trading of Chinese herbal medicines, as well as the production and sale of prepared slices of traditional Chinese medicine.
CEO: Yuling Chen
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Moomoo > Quotes > 01498 PURAPHARM > Detailed Quotes

01498 PURAPHARM

1.490+0.020+1.36%
Market Close 05/23 16:08 CCT
High
1.500
Open
1.460
Turnover
804.26K
Low
1.450
Pre Close
1.470
Volume
545.00K
Market Cap
588.39M
P/E(TTM)
Loss
52wk High
2.000
Shares
394.89M
P/E(Static)
Loss
52wk Low
0.670
Float Cap
588.39M
Bid/Ask %
-74.68%
Historical High
4.127
Shs Float
394.89M
Volume Ratio
0.81
Historical Low
0.560
Dividend TTM
--
Div Yield TTM
--
P/B
1.47
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.14%
Amplitude
3.40%
Avg Price
1.475
Lot Size
500
Float Cap
588.39M
Bid/Ask %
-74.68%
Historical High
4.127
Shs Float
394.89M
Volume Ratio
0.81
Historical Low
0.560
Dividend TTM
--
P/B
1.47
Dividend LFY
--
Turnover Ratio
0.14%
Amplitude
3.40%
Avg Price
1.475
Lot Size
500
Price Forecast

No Data

News

Comment